Cara Community

Community Discussion

In our community we students of the market openly discuss our various market insights and thoughtful opinions in support of a wider understanding of price behavior. Join us and share your thoughts!

9755
Leave a Reply

Please Login to comment
9755 Comment threads
0 Thread replies
12 Followers
 
Most reacted comment
Hottest comment thread
91 Comment authors
baz22skylerBill Carakaimujmugarian Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  Subscribe  
newest oldest
Notify of
baz22
Member
baz22

‘ and bingo was his name ‘! Bngo is getting fat !

skyler
Member
skyler

novavax up ~40% today. biotech’s been rising since it received fast track approval for it’s ‘influenza vaccine’:
https://finviz.com/quote.ashx?t=NVAX
https://finance.yahoo.com/news/novavax-rises-fast-track-designation-145202959.html

baz22
Member
baz22

Yeah… listen to the Sangamo CEO interview ( and posted) early last year… what caught my attention is when Sgmo CEO said ” if I were young and starting in this field ( gene editing ) today, I would go into Crispr research ” … good point, but Crispr is Sangamo’s biggest competition… I sold SGMO the next week….. will trade it only because their hemophilia A is now in Pfizer’s developmental clinical and Crisprs are not doing hemophilia, yet….This is Exactly why I say scientific journals Are the best source of information because any bias ( and there is… Read more »

skyler
Member
skyler

gm. Enerplus Corporation “. . exploration and development of crude oil and natural gas . .” https://finance.yahoo.com/news/enerplus-announces-2020-guidance-outlook-213500878.html

baz22
Member
baz22

As more and more viruses appear in human populations, mRna companies like Moderna will come to the rescue due to their speed ( vs egg based vaccines), precision and ability to adjust their uses as the viruses mutate… Moderna has big contracts with BARDA .

baz22
Member
baz22

Toby… options at Srpt are starting to jump…… ?

baz22
Member
baz22

Phase 2b underway

baz22
Member
baz22

Cassava PTI 125 improved insulin receptors thru it’s Filamin scaffolding ” by normalizing signaling thru a7 ” … PTI 125 ” prevents and reverses the binding ofAB 42 to a7nAChe, and reduced tau phosphorylation and amyloid deposition “.. ” P-tauT -181 and neurogranin fell by more than 30% while inflammatory markers fell from 5 to 14 % “.. phase 2a

baz22
Member
baz22

The circle of life Kaimu…. I was blessed to be with each of my parents on their last day on this earth. Love is the beginning and love is the ending… it’s all that really matters

kaimu
Member

Aloha! The ASX is in full swing this Sunday as the playoffs rumble on. I have to mention Silver Lake Res(SLR:ASX). This has been a 100% moneymaker as long as I have owned it. Up today some 10% on really good financials and an uptick in production guidance for FY2020. LINK: https://clients.weblink.com.au/news/pdf2/02193809.pdf Firing on all cylinders except that pesky “hedge”! But that is still an average $1900A gold price for the entire hedge, which is still profitable based on AISC numbers, but that is the risk when you hedge commodities. Still SLR has been a great run! Only one better… Read more »

kaimu
Member

Aloha! Bill and all many mahalos for the well wishes. The most amazing part of watching my Mother be 92 is how child like she has become and how I have become the “parent”! It is a blessing and a curse. Her independence has given way to innocence. It must be some sort of aura because I see nurses comment on how cute she is as if they are looking at a child.

It is an honor and my chosen duty to take care of her.

skyler
Member
skyler

right Kaimu, with big pharma subsidizing doctors not surprising though. its horrifying
to find your mom suffering like that. thankfully she is doing better, God bless.

baz22
Member
baz22

I am honestly looking for a bid from Novartis of $ 22 billion dollars ( US ) for Sarepta Therapeutics after the Sarepta-Roche, SRP- 9001 DMD sales agreement is closed in the first quarter of this year. Several analysts say the Roche premium payed takes Sarepta off the merger screen. I respectfully disagree . Sarepta will now have over $ 2 Billion in cash and Roche/Sarepta will split development costs/profits of SRP – 9001 down the middle. With the multitude of other programs in Sarepta’s pipeline and $ 500 Million yearly revenues, what’s not to like ? .. I believe… Read more »

baz22
Member
baz22

Kaimu… nothing stronger than the love of a mother and child…